74 | RanolazineFDA Link
01/2021
-
08/2004 |
42 | SodiumIBA
01/2020
-
08/2004 |
17 | Pharmaceutical PreparationsIBA
01/2020
-
12/2003 |
14 | Sodium Channels (Sodium Channel)IBA
01/2017
-
12/2006 |
13 | Adenosine (Adenocard)FDA LinkGeneric
01/2014
-
09/2003 |
10 | 6- (4- (trifluoromethoxy)phenyl)- 3- (trifluoromethyl)(1,2,4)triazolo(4,3- a)pyridineIBA
01/2020
-
01/2013 |
10 | Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2014
-
01/2005 |
8 | CalciumIBA
01/2018
-
07/2006 |
7 | Flecainide (Tambocor)FDA LinkGeneric
01/2022
-
10/2014 |
7 | Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2019
-
09/2011 |
7 | Neurofibromin 2 (Merlin)IBA
08/2015
-
10/2007 |
7 | regadenosonFDA Link
02/2012
-
01/2003 |
6 | Anti-Arrhythmia AgentsIBA
01/2021
-
03/2008 |
6 | eleclazineIBA
01/2018
-
01/2016 |
6 | DronedaroneFDA Link
01/2016
-
09/2010 |
6 | Glucose (Dextrose)FDA LinkGeneric
10/2015
-
05/2007 |
5 | E 4031IBA
01/2020
-
09/2009 |
5 | 3- ethyl- 1- propyl- 8- (1- (3- trifluoromethylbenzyl)- 1H- pyrazol- 4- yl)- 3,7- dihydropurine- 2,6- dioneIBA
01/2014
-
08/2006 |
5 | Nonesterified Fatty Acids (NEFA)IBA
04/2013
-
04/2003 |
4 | Metoprolol (Toprol-XL)FDA LinkGeneric
01/2020
-
02/2006 |
4 | Amiodarone (Amiodarona)FDA LinkGeneric
03/2017
-
02/2008 |
4 | Epinephrine (Adrenaline)FDA LinkGeneric
01/2017
-
12/2015 |
4 | 2- (6- ((2- hydroxycyclopentyl)amino)purin- 9- yl)- 5- ((2- fluorophenylthio)methyl)oxolane- 3,4- diolIBA
04/2013
-
05/2006 |
4 | Fatty Acids (Saturated Fatty Acids)IBA
01/2009
-
02/2007 |
3 | Adrenergic Agents (Adrenergic Drugs)IBA
01/2019
-
12/2015 |
3 | CatecholaminesIBA
01/2018
-
12/2015 |
3 | Proteins (Proteins, Gene)FDA Link
01/2017
-
01/2014 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
10/2016
-
07/2006 |
3 | Acetylcholine (Acetylcholine Chloride)FDA Link
04/2016
-
07/2009 |
3 | Nitroglycerin (Dynamite)FDA LinkGeneric
11/2014
-
05/2013 |
3 | beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
12/2012
-
09/2003 |
3 | Vasodilator Agents (Vasodilators)IBA
02/2012
-
10/2009 |
3 | Tetrodotoxin (Tetradotoxin)IBA
04/2011
-
11/2008 |
3 | para- trifluoro- methyl- 5- phenyl- 1,2,4- oxadiazoleIBA
04/2008
-
02/2007 |
3 | tecadenosonIBA
06/2005
-
04/2003 |
2 | toxin II (Anemonia sulcata)IBA
01/2020
-
08/2004 |
2 | ChloraloseIBA
04/2016
-
01/2016 |
2 | IvabradineIBA
03/2015
-
12/2014 |
2 | EnalaprilFDA LinkGeneric
01/2014
-
11/2008 |
2 | Bleomycin (Blenoxane)FDA LinkGeneric
06/2012
-
08/2006 |
2 | Sotalol (Sotalol Hydrochloride)FDA LinkGeneric
04/2011
-
08/2004 |
2 | Interleukin-6 (Interleukin 6)IBA
02/2010
-
01/2005 |
2 | Purinergic P1 Receptor AgonistsIBA
02/2006
-
01/2004 |
2 | Interleukin-11 (Interleukin 11)IBA
03/2002
-
03/2002 |